Temozolomide in Treating Patients With Progressive Low-Grade Glioma [clinicaltrials:NCT00003466]
Temozolomide in Treating Patients With Progressive Low-Grade Glioma [clinicaltrials:NCT00003466]
Bio2RDF identifier
NCT00003466
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00003466
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... progressive low-grade glioma.
brief title [clinicaltrials_vocabulary:brief-title]
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2005-07-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
- ...... s
study within 3 years.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
adult brain stem glioma
adult diffuse astrocytoma
adult mixed glioma
adult oligodendroglioma
adult pilocytic astrocytoma
adult subependymoma
childhood mixed glioma
recurrent adult brain tumor
recurrent childhood brain stem glioma
recurrent childhood cerebral astrocytoma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2014-07-07T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00003466
official title [clinicaltrials_vocabulary:official-title]
Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal
org study id [clinicaltrials_vocabulary:org-study-id]
1703 (CDR0000066502)
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2005-07-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
DUMC-1703-04-12R7
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-02-01T00:00:00Z
identifier
clinicaltrials:NCT00003466
title
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
@en
type
label
Temozolomide in Treating Patie ...... a [clinicaltrials:NCT00003466]
@en